Johanna E. Rausch

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism.

Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism.

Journal: Frontiers in immunology

Published: April 01, 2025

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.

Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.

Journal: Frontiers in immunology

Published: July 28, 2023

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.

Journal: Haematologica

Published: September 25, 2022

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation.

Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation.

Journal: Circulation research

Published: August 26, 2021

COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.

COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.

Journal: Hamostaseologie

Published: July 30, 2021

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 15, 2021

Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia.

Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 18, 2020

Repurposing mesalazine against cardiac fibrosis in vitro.

Repurposing mesalazine against cardiac fibrosis in vitro.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 18, 2020

Modeling atrial fibrosis in vitro-Generation and characterization of a novel human atrial fibroblast cell line.

Modeling atrial fibrosis in vitro-Generation and characterization of a novel human atrial fibroblast cell line.

Journal: FEBS open bio

Published: March 05, 2020

Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.

Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.

Journal: Blood

Published: January 24, 2020

Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice.

Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice.

Journal: European journal of immunology

Published: December 12, 2018

Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization.

Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization.

Journal: Journal of dermatological science

Published: June 07, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026